← Search

Omics · study · 2026

Single nucleus RNA sequencing analysis reveals transcriptional heterogeneity of endometrioid endometrial cancer

Listed in NCBI GEO

Endometrial cancer (EC) is the sixth most prevalent malignancy affecting women worldwide, with an increasing incidence that poses a substantial public health challenge.

Description

This study investigates the tumor microenvironment (TME) of EC, particularly high grade endometrioid endometrial cancer (HEEC), utilizing single nucleus RNA sequencing (snRNA-seq). The analysis encompassed normal endometrium (NE), HEEC, middle grade endometrioid endometrial cancer (MEEC), and low grade endometrioid endometrial cancer (LEEC).

Significant cellular heterogeneity was identified within the TME, including immune cells, fibroblasts, and epithelial cells. Notably, SULF1+ NREP+ fibroblasts were significantly enriched in HEEC and associated with aggressive tumor behavior. Additionally, the study highlighted the overexpression of metabolic pathways and immune checkpoint molecules in HEEC epithelial cells, including Human Leukocyte Antigen E (HLA-E) and Killer Cell Lectin Like Receptor C1 (KLRC1), which may contribute to immune evasion and enhanced tumor aggressiveness.

Read the rest (2 more)

Identifying the EYA transcriptional coactivator and phosphatase 1 (EYA1) gene as a prospective biomarker in HEEC due to its association with poor prognosis and the enhanced proliferative and migratory capabilities of EC cells. Furthermore, analyses of cell-cell interactions revealed critical signaling pathways, such as the Leucocyte Associated Immunoglobulin Like Receptor-1 (LAIR1)- Leukocyte Immunoglobulin-like Receptor B4 (LILRB4) axis in macrophages, which may play a role in immune suppression and EEC progression.

A comprehensive single-cell level characterization of the TME in EEC offers critical insights into the molecular mechanisms driving EEC progression, while identifying potential therapeutic targets. These discoveries advance our understanding of EEC pathophysiology and hold promise for the development of targeted therapies, particularly in HEEC

Links

Where it is published

Documentation and papers

Topics

From keywords
Life Sciences
Inferred from text
Cancer 75% · RNA sequencing 75% · Sequencing 75% · Single-cell RNA sequencing 65%
Provenance · 1 source records, 11 field assertions
SourceKeyLast seenRaw
NCBI GEOGSE27887915 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[disease].local:disease:cancerenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[field].local:field:life-sciencesmapping · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[method].geo_series_type:expression-profiling-by-high-throughput-sequencingsource · NCBI GEOconnector:ncbi_geo@1.0.0/gdstype
concepts[modality].local:modality:rna-seqenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[modality].local:modality:sequencingenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[modality].local:modality:single-cell-rna-seqenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (65%)
concepts[organism].NCBITaxon:9606source · NCBI GEOconnector:ncbi_geo@1.0.0/taxon
descriptionsource · NCBI GEOconnector:ncbi_geo@1.0.0/summary
publication_datesource · NCBI GEOconnector:ncbi_geo@1.0.0
titlesource · NCBI GEOconnector:ncbi_geo@1.0.0/title